nanotechnology news from FierceBioResearcher
NewsNanoparticle program delivers anti-cancer therapy
A research team at Washington University in St. Louis has combined a nanoparticle platform used in imaging growing blood vessels and combined it with the fungal drug fumagillin to create a new Read more...
Nanotech advocates seek new federal research funds
Leaders in the nanotech field have been beating a path to Congress, asking lawmakers to significantly boost federal support of research into molecular-level advances. Currently, taxpayers fund about Read more...
Trials test ultrasound as cancer weapon
Scientists at the University of Oxford are preparing clinical trials to test a new way to treat kidney and liver tumors. Ultrasound waves will be directed to tumors, where bubbles will develop and Read more...
Fat bubbles used to deliver chemo
Tiny fat bubbles can be used to deliver powerful chemotherapy drugs to the site of tumors. Investigators at Duke University have been injecting chemotherapy into fat liposomes and injecting them Read more...
Nanoparticles may be key for new pain therapy
The Defense Advanced Research Projects Agency, or DARPA, is funneling $1.3 million to researchers at the University of Michigan to see if they can use nanoparticles to transform the way morphine is Read more...
FDA to address nanotech standards
Nanotechnology has enormous potential to revolutionize the drug, medical device, cosmetic and food industries, but according to a new report, the FDA lacks a standard regulatory procedure for Read more...
Nanoparticle developed for new drug delivery systemA scientist at the University of Central Florida has helped develop a nanoparticle that apparently helps deliver high concentrations of medicine for treating glaucoma. The tiny size of the particle allows it to penetrate the blood-brain barrier that typically obstructs therapies. Sudipta Seal, an engineering professor with appointments in UCF's Advanced Materials Processing and Analysis Center and the Nanoscience Technology Center, says that only 1 percent to 3 percent of existing … Read more...Israeli group creating fund for drug researchThe Israeli Life Sciences Industry group is helping set up a $300 million to $500 million initiative to spur the development of biotechnology and help finance drug research in the country. Chief Scientist Dr. Eli Opper says that the country is already in negotiations with multinational biotech companies to create development centers in Israel while the government is adding to the biotech/nanotech activities of Israel's universities. Care Capital partner Dr. Argeris N. Karabelas told the … Read more...Nanomaterials used to fix neuron damageNorthwestern University researcher Samuel Stupp has presented the results of a study in which he injected nanomaterials into the severed spinal cords of mice, allowing them to walk again after several weeks of therapy. The nanomaterials he used were designed to self-assemble into nanofibers which repaired damaged neurons. The research offers new insights into the near-term research potential of nanotechnology and offers hope for patients with Alzheimer's and Parkinson's who suffer from … Read more...Drug delivery vehicles' shape could determine efficacyA group of researchers at the University of Pennsylvania say that string-like nanoparticles survive longer than spherically shaped nanoparticles, which leads them to believe that the right shape is a key concern in designing new delivery vehicles for drugs. Dennis Discher and colleagues at the University of Pennsylvania say that string-like nanoparticles circulated for up to a week in rodents, significantly longer than the carbon nanotubes that have been studied in depth. Their work … Read more... | Press ReleasesPRESS RELEASE: New nanoparticle vaccine is more effective but less expensive New nanoparticle vaccine is more effective but less expensive Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a Read more... |
Get more nanotechnology coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

